Работа посвящена вопросам лекарственного лечения меланомы кожи. Современное
лекарственное лечение меланомы кожи включает иммунную, таргетную и, в меньшей …

Prenylated Rab Acceptor 1 (PRA1/Rabac1) is a four-pass transmembrane protein that has
been found to localize to the Golgi and promiscuously associate with a diverse array of Rab …

Melanoma is one of the variable nature and deadliest form of skin cancers and the mutations
play a major role in its development. It has faced many challenges in treatment and has led …

The MAPK signaling pathway with BRAF mutations has been shown to drive the
pathogenesis of 40-60% of melanomas. Inhibitors of this pathway's BRAF and MEK …

Adoptif hücre tedavileri (ACT) son yıllarda malign melanomlu hastalar için mevcut en iyi
immünoterapi seçeneklerinden biridir. Tümörün baskılayıcı mikroçevresinden dolayı anti …

Заболеваемость меланомой кожи в мире растет с каждым годом. Несмотря на
достижения в области диагностики, выявление первичного очага меланомы в …

Abstract CILJ ISTRAŽIVANJA: Mutacije BRCA1 i BRCA2 gena su poznati čimbenici rizika za
nastanak raka dojke i jajnika. Spektar BRCA1/2 mutacija u bolesnica sa seroznim …

Objective: Colorectal cancer (CRC) is a type of cancer spreading quickly around the world.
Melanoma is an aggressive and lethal form of skin cancer. One of the striking biomarkers in …

Background: Cutaneous melanoma represents one of the most frequent cancers in the adult
population and accounts for more than 80% of skin cancer deaths. Due to pharmacological …

The incidence of skin melanoma in the world is growing every year. Despite advances in
diagnostics, the identification of the primary focus of melanoma in some cases is still difficult …